Disclosure 0001193125-26-401237-2

SEC FORM 4

$626,459.60

CRISPR Therapeutics AG (CRSP)

Sale of 10,400 shares at $60.2365 per share.

Reporting Person KASINGER JAMES R. · Officer Title General Counsel and Secretary · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001193125-26-401237 · filed 2026-09-24 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "CRISPR Therapeutics AG (CRSP)." Disclosed 2026-09-24. https://desqlong.com/cards/0001193125-26-401237-2 (retrieved 2026-09-26).